Items tagged with Access
South Africa: MPs shun public TB testing (post with simple image)
A call by the Treatment Action Campaign (TAC) and partner organisations for Members of Parliament (MP's) to get tested for tuberculosis (TB), which is one of the leading causes of deaths in South Africa, has fallen on deaf ears.
New WHO report shows that transparency and cooperation help to reduce high prices for new medicines (post with simple image)
As the number of new medicines introduced in Europe rises, governments are finding it increasingly difficult to afford them, according to a comprehensive study released today by the WHO Regional Office for Europe. The study illustrates the challenges for national health systems, with specific examples, and shows that few countries in the WHO European Region have mechanisms in place to evaluate the cost–effectiveness of new drugs; this hampers the value-assessment and decision-making processes.
The bedaquiline donation program started on April 1 (post with simple image)
A webinar, explaining the bedaquiline donation program, will be conducted on April 14, 2015 at 8:00 am EST and can be accessed here.
Ukraine: The price for the medicines procured by the international organizations for state programs will decrease by 42% (post with simple image)
Verkhovna Rada of Ukraine passed the draft law №2151 which enables the transfer of drug procurement to the international organizations. This draf law provides for the abolition of 7% VAT and 5% customs duty on drugs that will be procured by the international organization for the state budget. Together with the draft law № 2150, which was passed by the Parliament on March 19, 2015, the saved funds on the drug procurement through international organizations will reach 42%. Additionally around 1.5 million Ukrainians will receive treatment and vaccination due to the savings.
Nigeria spends nearly US$1.5 million for procurement of treatment for people with multidrug-resistant TB (post with simple image)
The Nigerian government sanctioned US$1.42 million to procure quality assured Second Line Drugs (SLDs) that will be used to provide treatment for 500 multidrug-resistant TB (MDR-TB) patients. The second line drugs ordered by the government will be delivered by Stop TB Partnership’s Global Drug Facility starting June 2015.
How to access the bedaquiline donation program: step by step (post with simple image)
This is a note for implementers providing a general overview and reviewing the steps they need to take in order to access the drug.
MSF response to announcement of Otsuka’s donation programme for the TB drug delamanid (post with simple image)
MSF continues to express concern over the use of limited-scope donation programmes as a primary means of providing access to new TB drugs in countries affected by drug-resistant TB, as they are not a long-term solution to facilitating scale-up of treatment.
WHO moves to improve access to lifesaving medicines for hepatitis C, drug-resistant TB and cancers (post with simple image)
New WHO Model List of Essential Medicines published; After about 45 years of scarce innovation for TB medicines, 5 new products are included in the List. Four of these, including bedaquiline and delamanid, target multidrug-resistant TB.
Letter from TB community re: intellectual property rights to sutezolid (post with simple image)
The letter urges Johns Hopkins to assure the timely and responsible development of TB drug candidate sutezolid if transferring any intellectual property rights to Sequella.
Lack of medicines in Ukraine a ‘major problem’, says UN (post with simple image)
Millions of people displaced or severely affected by the conflict in Ukraine are in dire need of basic services, with the lack of medicines and vaccines a major concern, a new United Nations (UN) report has warned.
Page 60 of 83 · Total posts: 0
←First 59 60 61 Last→